{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:32:34Z","timestamp":1783402354455,"version":"3.54.6"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>An inactivating <jats:italic>PHEX<\/jats:italic> gene mutation with the resultant accumulation of several mineralization-inhibiting proteins (e.g., FGF23) causes skeletal and dental morbidity in X-linked hypophosphatemia (XLH). This prospective case-control study explored the effect of burosumab, an anti-FGF23 antibody, on dental health of children with XLH. Ten children (age 4.3-15 years) with XLH underwent burosumab treatment per protocol. Assessment of their dental status at treatment initiation and after 1 and 3 years of treatment included clinical, laboratory and radiographic evaluation of rickets and dentition. Orthopantomographic examinations of ten healthy sex- and age-matched controls were selected for comparison. Coronal and pulp dimensions of a selected permanent mandibular molar were measured with Planmeca Romexis<jats:sup>\u00ae<\/jats:sup> software. One year of treatment led to improvement of height z-score (<jats:italic>p<\/jats:italic>=0.019) and healing of the rickets (<jats:italic>p<\/jats:italic>&amp;lt;0.001) in the XLH patients, and those achievements were maintained after three years of treatment. Dental morphology of XLH patients, distinguished by increased pulp-coronal ratios compared to controls (<jats:italic>p<\/jats:italic>=0.002), remained larger after the first year of treatment (<jats:italic>p<\/jats:italic>&amp;lt;0.001) and did not attain the decrease expected with age after three years of treatment. Five patients had a history of recurrent dental abscesses, with three having undergone at least one episode during the year before burosumab initiation. One patient sustained recurrent abscesses throughout three years of treatment. The persistence of the unique dental morphology of XLH patients undergoing burosumab therapy, as evidenced by excessively larger pulp dimensions, supports the role of other <jats:italic>PHEX<\/jats:italic> gene-related local mineralization inhibitors, such as osteopontin, in the pathogenesis of dental morbidity.<\/jats:p>","DOI":"10.3389\/fendo.2022.947814","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:01:00Z","timestamp":1660539660000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Rafi","family":"Brener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Lebenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivit","family":"Brener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4035","article-title":"Functional characterization of PHEX gene variants in children with X-linked hypophosphatemic rickets shows no evidence of genotype\u2013phenotype correlation","volume":"35","author":"Zheng","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1766","article-title":"Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in hyp mouse bone, the murine model of X-linked hypophosphatemia","volume":"28","author":"Barros","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056749","article-title":"MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia","volume":"8","author":"Salmon","year":"2013","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.11.019","article-title":"Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia","volume":"95","author":"Boukpessi","year":"2017","journal-title":"Bone"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PloS Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-016-1357-6","article-title":"The FGF23 and klotho system beyond mineral metabolism","volume":"21","author":"Kuro-o","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00841-4","article-title":"Characterization of oral health status in Chilean patients with X-linked hypophosphatemia","volume":"109","author":"Marin","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-015-1425-4","article-title":"Review of the dental implications of X-linked hypophosphataemic rickets (XLHR)","volume":"19","author":"Sabandal","year":"2015","journal-title":"Clin Oral Investig"},{"key":"B10","article-title":"Dental problems in hypophosphatemic rickets, a cross sectional study","volume":"22","author":"Rabbani","year":"2012","journal-title":"Iran J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1136\/bcr-2012-008318","article-title":"Oral manifestations of vitamin d resistant rickets in orthopantomogram","volume":"12","author":"Rathore","year":"2013","journal-title":"BMJ Case Rep"},{"key":"B12","first-page":"69","article-title":"X-Linked hypophosphatemia: Dental and histologic findings","volume":"72","author":"Batra","year":"2006","journal-title":"J Can Dental Assoc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01136-8","article-title":"Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets","volume":"39","author":"Baroncelli","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00669-9","article-title":"Burosumab for pediatric X-linked hypophosphatemia","volume":"19","author":"Imel","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"B17","first-page":"1","article-title":"2000 CDC Growth charts for the united states: methods and development","volume":"11","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"key":"B18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"B20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bone.2019.02.010","article-title":"Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic rickets severity score","volume":"122","author":"Thacher","year":"2019","journal-title":"Bone"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1097\/00000441-195909000-00030","volume-title":"Radiographic atlas of the skeletal development of the hand and wrist","author":"Greulich","year":"1959"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ajpa.22473","article-title":"Accuracy of dental age estimation charts: Schour and massler, Ubelaker and the London atlas","volume":"154","author":"AlQahtani","year":"2014","journal-title":"Am J Phys Anthropol"},{"key":"B23","article-title":"International standard 3950-1984(E). dentistry\u2013designation system for teeth and areas of the oral cavity","volume":"30","year":"1985","journal-title":"Aust Dent J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2011.07.028","article-title":"Age estimation by pulp\/tooth ratio in lower premolars by orthopantomography","volume":"214","author":"Cameriere","year":"2012","journal-title":"Forensic Sci Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05484-7","article-title":"Real-world effectiveness of burosumab in children with X-linked hypophosphatemic rickets","author":"Paloian","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211001150","article-title":"Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy","volume":"16","author":"Brener","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-2399(85)80225-9","article-title":"Dental observations in vitamin d-resistant rickets with special reference to periapical lesions","volume":"11","author":"Bender","year":"1985","journal-title":"J Endod"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa495","article-title":"Growth curves for children with X-linked hypophosphatemia","volume":"105","author":"Mao","year":"2020","journal-title":"J Clin Endocrin ol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","article-title":"The expanding family of hypophosphatemic syndromes","volume":"30","author":"Carpenter","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/0022034516677528","article-title":"Phosphate and vitamin d prevent periodontitis in X-linked hypophosphatemia","volume":"96","author":"Biosse Duplan","year":"2017","journal-title":"J Dent Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/eos.12836","article-title":"Dental caries severity and oral health-related quality-of-life in Brazilian preschool children","volume":"130","author":"Fernandez","year":"2022","journal-title":"Eur J Oral Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12903-021-01912-6","article-title":"Inequality in dental care expenditure in Iranian households: analysis of income quintiles and educational levels","volume":"21","author":"Najafi","year":"2021","journal-title":"BMC Oral Health"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2018.05.102","article-title":"Periodontal disease, systemic inflammation and the risk of cardiovascular disease","volume":"27","author":"Carrizales-Sep\u00falveda","year":"2018","journal-title":"Heart Lung Circ"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/2040622318804753","article-title":"Vibrational spectroscopic analysis of hydroxyapatite in HYP mice and individuals with X-linked hypophosphatemia","volume":"9","author":"Amenta","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/0022034517728497","article-title":"Defective mineralization in X-linked hypophosphatemia dental pulp cell cultures","volume":"97","author":"Coyac","year":"2018","journal-title":"J Dent Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116025","article-title":"Monitoring response to conventional treatment in children with XLH: Value of ALP and rickets severity score (RSS) in a real world setting","volume":"151","author":"Uday","year":"2021","journal-title":"Bone"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: Effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.641543","article-title":"Consensus recommendations for the diagnosis and management of X-linked hypophosphatemia in Belgium","volume":"12","author":"Laurent","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4103\/0975-1475.114552","article-title":"Adult forensic age estimation using mandibular first molar radiographs: A novel technique","volume":"5","author":"Mathew","year":"2013","journal-title":"J Forensic Dent Sci"},{"key":"B41","article-title":"1,25- dihydroxyvitamin d and anti-FGF23 blocking antibody treatments improve dentoalveolar tissues in the hyp mouse model of X-linked hypophosphatemia","volume-title":"American Society for bone and mineral research annual meeting online 2020","author":"Liu","year":"2020"},{"key":"B42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/03008207.2014.923864","article-title":"Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth","volume":"1","author":"Salmon","year":"2014","journal-title":"Connect Tissue Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2006.01326.x","article-title":"Dentin structure in familial hypophosphatemic rickets: benefits of vitamin d and phosphate treatment","volume":"13","author":"Chaussain-Miller","year":"2007","journal-title":"Oral Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.947814\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T12:42:05Z","timestamp":1660653725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.947814\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.947814"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.947814","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"article-number":"947814"}}